SynCardia Systems, Inc. Regulatiory and Approvals FDA, CE Mark and Health Canada Approvals of SynCardia Systems, Inc. Devices Videos from Client Health & Healthcare FDA Approves the SynCardia Total Artificial Heart for Destination Therapy Study Jan 7, 2015 12:10 PM ET Read the full story Content from this campaign Health & Healthcare FDA Approves Investigational Study for New Smaller SynCardia Total Artificial Heart Tuesday, March 31, 2015 - 18:45 Health & Healthcare FDA Approves the SynCardia Total Artificial Heart for Destination Therapy Study Wednesday, January 7, 2015 - 12:10 More from SynCardia Systems, Inc. SynCardia Awards and Recognition SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE... SynCardia Systems, Inc. SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE... SynCardia Total Artificial Heart Patients in the News Highest bridge to human heart transplant rate of any approved heart device, 79% Over 1,350 implants account for nearly 400 patient years on the... SynCardia temporary Total Artificial Heart The SynCardia Total Artificial Heart is the world's first & only FDA, Health Canada and CE approved Artificial Heart. SynCardia Systems, Inc. Regulatiory and Approvals FDA, CE Mark and Health Canada Approvals of SynCardia Systems, Inc. Devices SynCardia Total Artificial Heart Professional Papers Professional Papers, Abstracts and Case Studies of the SynCardia temporary Total Artificial Heart around the globe. Artificial Heart For patients suffering from end-stage biventricular (both sides) heart failure, a donor heart transplant is the standard of care. However, not all... Scholarships at SynCardia Systems, Inc. The Anna Salazar Memorial Engineering Scholarship, funded by SynCardia Systems, Inc., seeks to support female University of Arizona College of...
Health & Healthcare FDA Approves the SynCardia Total Artificial Heart for Destination Therapy Study Jan 7, 2015 12:10 PM ET Read the full story
SynCardia Awards and Recognition SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE...
SynCardia Systems, Inc. SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world's first and only FDA, Health Canada and CE...
SynCardia Total Artificial Heart Patients in the News Highest bridge to human heart transplant rate of any approved heart device, 79% Over 1,350 implants account for nearly 400 patient years on the...
SynCardia temporary Total Artificial Heart The SynCardia Total Artificial Heart is the world's first & only FDA, Health Canada and CE approved Artificial Heart.
SynCardia Systems, Inc. Regulatiory and Approvals FDA, CE Mark and Health Canada Approvals of SynCardia Systems, Inc. Devices
SynCardia Total Artificial Heart Professional Papers Professional Papers, Abstracts and Case Studies of the SynCardia temporary Total Artificial Heart around the globe.
Artificial Heart For patients suffering from end-stage biventricular (both sides) heart failure, a donor heart transplant is the standard of care. However, not all...
Scholarships at SynCardia Systems, Inc. The Anna Salazar Memorial Engineering Scholarship, funded by SynCardia Systems, Inc., seeks to support female University of Arizona College of...
